Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Resectable”

232 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 232 results

Not applicableLooking for participantsNCT05248581
What this trial is testing

Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer Metastatic
University of Rochester 25
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Testing effectiveness (Phase 2)UnknownNCT05578430
What this trial is testing

AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Who this might be right for
Resectable Hepatocellular Carcinoma
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Large-scale testing (Phase 3)Looking for participantsNCT05985798
What this trial is testing

Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 258
Not applicableStudy completedNCT04177316
What this trial is testing

Hypermethylation of VTRNA2-1 Promoter in HCC Outcome

Who this might be right for
Hepatocellular Carcinoma Resectable
Chang Gung Memorial Hospital 92
Large-scale testing (Phase 3)Active Not RecruitingNCT03298451
What this trial is testing

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,324
Testing effectiveness (Phase 2)WithdrawnNCT03563170
What this trial is testing

QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma Recurrent
ImmunityBio, Inc.
Testing effectiveness (Phase 2)UnknownNCT02452853
What this trial is testing

HR Combined With FOLFOX4 for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 51
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Not applicableStudy completedNCT03533920
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Jeil Pharmaceutical Co., Ltd. 62
Testing effectiveness (Phase 2)Study completedNCT04511455
What this trial is testing

Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment

Who this might be right for
Hepatocellular Carcinoma Non-resectableMetastatic Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04721132
What this trial is testing

Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

Who this might be right for
Resectable Hepatocellular CarcinomaStage I Hepatocellular Carcinoma AJCC v8Stage IA Hepatocellular Carcinoma AJCC v8+2 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT04850157
What this trial is testing

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 30
Not applicableStudy completedNCT03138031
What this trial is testing

Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
The National Ribat University 23
Testing effectiveness (Phase 2)Study completedNCT05908786
What this trial is testing

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06524466
What this trial is testing

Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma

Who this might be right for
Resectable Hepatocellular CarcinomaMacrovascular InvasionCNLC IIIA Stage
Sun Yat-sen University 35
Large-scale testing (Phase 3)UnknownNCT05056337
What this trial is testing

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 220
Load More Results